- P&G’s organic revenue increased by 3%, surpassing the estimated growth of 2.35%.
- Beauty segment saw a 2% increase in organic sales, widely beating the negative estimate of -0.38%.
- Grooming organic sales rose by 2%, slightly under the estimate of 2.48%.
- Healthcare sector’s organic sales grew by 3%, falling short of the 6.04% estimation.
- Fabric & Home Care organic sales increased by 3%, closely aligning with the 3.06% estimate.
- Baby, Feminine & Family Care organic sales surged by 4%, far exceeding the estimated 0.94% growth.
- Core earnings per share (EPS) were $1.88, above both last year’s $1.84 and the estimate of $1.86.
- Net sales reached $21.88 billion, a 2.1% year-over-year increase, surpassing the $21.55 billion estimate.
- Beauty segment revenue was $3.85 billion, exceeding the $3.75 billion estimate.
- Grooming segment reported $1.75 billion in revenue, slightly above the estimated $1.73 billion.
- Healthcare revenue came in at $3.25 billion, which is below the forecast of $3.31 billion.
- Fabric & Home Care revenue was $7.58 billion, surpassing the $7.51 billion estimate.
- Baby, Feminine & Family Care revenue reached $5.30 billion, outpacing the expected $5.11 billion.
- The foreign currency impact on sales was neutral, better than the projected -1.53% impact.
- Price impact was 0%, missing the estimate of a 0.82% increase.
- There was a 2% organic volume growth, more than doubling the 0.91% estimate.
- Gross margin was 52.4%, slightly under the estimated 52.5%.
- Adjusted free cash flow was $3.90 billion, below the estimated $4.1 billion.
- Year forecast maintains organic revenue growth between 3% and 5%, compared to an estimate of 2.99%.
- Core EPS growth is still expected to be between 5% and 7%.
- Core EPS projection remains between $6.91 and $7.05, aligning with the $6.91 estimate.
- The company anticipates a $200 million after-tax commodity cost headwind for fiscal 2025.
- Prior year benefits from minor brand divestitures and favorable tax impacts are not expected to repeat, adding an extra $0.10 to $0.12 headwind to core EPS.
- Sales increase was driven by a 2% rise in organic volume and a 1% uplift from a favorable geographic mix.
“`
Procter & Gamble Co on Smartkarma
Analysts at Baptista Research on Smartkarma are closely monitoring Procter & Gamble Co, delving into the company’s recent performance and future prospects. In a report titled “Procter & Gamble’s China Woes Continue! What’s Driving Their Future Performance? – Financial Forecasts,” the analysts highlighted the nuanced business operations of Procter & Gamble. Despite a modest 2% increase in organic sales growth, the report explores varied performance across different geographies and market segments, projecting a cautiously optimistic outlook tempered by prevailing market challenges.
Another report from Baptista Research focuses on PG&E Corporation, providing insights into the company’s performance for the second quarter of 2024. Titled “PG&E Corporation: Company Overview,” the analysis showcases steady progress with core earnings per share of $0.31 and a reaffirmed 2024 earnings guidance of $1.33 to $1.37 per share. This performance indicates a positive trend for PG&E Corporation, known for supplying electricity and natural gas throughout California, with a projected increase of at least 10% from the previous year.
A look at Procter & Gamble Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
The Smartkarma Smart Scores for Procter & Gamble Co indicate a balanced long-term outlook. With solid scores in Growth, Resilience, and Momentum, the company seems well-positioned to maintain steady performance and adapt to changing market conditions. While the Value score is moderate, Procter & Gamble Co‘s strengths lie in its ability to grow and withstand economic uncertainties, backed by a consistent dividend payout.
Procter & Gamble Co, a global consumer products manufacturer, has a diversified product portfolio spanning various segments from laundry and cleaning to health care. The company’s widespread distribution network includes mass merchandisers, grocery stores, and drug stores, ensuring broad market reach. Based on the Smartkarma Smart Scores, Procter & Gamble Co shows promise in terms of growth potential, resilience, and momentum, reflecting a stable outlook for the company’s performance in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
